Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Miragen Therapeutics Inc patents


Recent patent applications related to Miragen Therapeutics Inc. Miragen Therapeutics Inc is listed as an Agent/Assignee. Note: Miragen Therapeutics Inc may have other listings under different names/spellings. We're not affiliated with Miragen Therapeutics Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "M" | Miragen Therapeutics Inc-related inventors


Mir-155 inhibitors for treating cutaneous t cell lymphoma (ctcl)

The present invention provides oligonucleotide inhibitors of mir-155 and compositions thereof. The invention further provides methods for treating cancer such as a t cell lymphoma in a subject by administering to the subject an oligonucleotide inhibitor of mir-155. ... Miragen Therapeutics Inc

Inhibitors of myh7b and uses thereof

The present invention provides nucleic acid inhibitors of myh7b and compositions thereof. The present invention also provides methods of treating or preventing a cardiac disorder such as cardiac hypertrophy, myocardial infarction, or heart failure in a subject by administering to the subject an inhibitor of myh7b. ... Miragen Therapeutics Inc

Mirna mimetics and their use in treating sensory conditions

The present invention provides microrna mimetic compounds that mimic the function or activity of mir-96, mir-182, and/or mir-183. The microrna mimetic compounds of the invention comprise a first strand of about (22) to about (26) ribonucleotides comprising a mature mir-96, mir-182, or mir-183 sequence; and a second strand of about (20) to about (24) ribonucleotides comprising a sequence that is substantially complementary to the first strand and having at least one modified nucleotide, wherein the first strand has a 3′ nucleotide overhang relative to the second strand. ... Miragen Therapeutics Inc

Oligonucleotide compositions and uses thereof

The present invention provides oligonucleotide inhibitors of mir-155 and compositions thereof. The invention further provides methods for treating cancer such as a t cell lymphoma in a subject by administering to the subject an oligonucleotide inhibitor of mir-155. ... Miragen Therapeutics Inc

Synthesis of bicyclic nucleosides

The present disclosure provides methods for synthesizing modified nucleosides, nucleotides, and oligonucleotides comprising at least one 2′-c-bridged bicyclic nucleotide, and to intermediates used in the process.. . ... Miragen Therapeutics Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Miragen Therapeutics Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Miragen Therapeutics Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###